Marrone Bio Innov (MBII) Misses Q1 EPS by 14c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Marrone Bio Innovations Reports First Quarter 2014 Financial Results
May 13, 2014 4:02 PM EDTGained EPA approval and commercially launched Venerate bioinsecticide Completed installation of two 20,000 liter fermentation tanks at our Michigan facility and initiated commercial production of fermentation products Re-iterates guidance to at least double revenues year-over-year
DAVIS, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (Nasdaq: MBII), a provider of bio-based pest management and plant health products, today announced financial results for the first quarter March 31, 2014.
Financial Highlights for the First Quarter of 2014
Revenues for the first quarter 2014 totaled $2.8 million, compared to... More